0001104659-24-005581.txt : 20240122 0001104659-24-005581.hdr.sgml : 20240122 20240122162248 ACCESSION NUMBER: 0001104659-24-005581 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240122 DATE AS OF CHANGE: 20240122 EFFECTIVENESS DATE: 20240122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Intrommune Therapeutics, Inc. CENTRAL INDEX KEY: 0001736977 ORGANIZATION NAME: IRS NUMBER: 364782195 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-503082 FILM NUMBER: 24549112 BUSINESS ADDRESS: STREET 1: 20 WEST 125TH ST STREET 2: SUITE 1 CITY: NEW YORK STATE: NY ZIP: 10027 BUSINESS PHONE: 6464948432 MAIL ADDRESS: STREET 1: 20 WEST 125TH STREET STREET 2: SUITE#1 CITY: NEW YORK STATE: NY ZIP: 10027 FORMER COMPANY: FORMER CONFORMED NAME: ZENII, LLC DATE OF NAME CHANGE: 20180410 D 1 primary_doc.xml X0708 D LIVE 0001736977 Intrommune Therapeutics, Inc. 20 W 125TH ST. UNIT #1 NEW YORK NY NEW YORK 10027 6464948432 DELAWARE ZENII LLC ZENII, LLC Corporation true 2021 Michael Nelson c/o Intrommune Therapeutics, Inc. 20 W 125TH ST. UNIT #1 NEW YORK NY NEW YORK 10027 Executive Officer Director William Reisacher c/o Intrommune Therapeutics, Inc. 20 W 125TH ST. UNIT #1 NEW YORK NY NEW YORK 10027 Director Erick Berglund c/o Intrommune Thereapeutics, Inc. 20 W 125TH ST. UNIT #1 NEW YORK NY NEW YORK 10027 Director Jonathan Rich c/o Intrommune Therapeutics, Inc. 20 W 125TH ST. UNIT #1 NEW YORK NY NEW YORK 10027 Director Hemanshu Pandya c/o Intrommune Therapeutics, Inc. 20 W 125TH ST. UNIT #1 NEW YORK NY NEW YORK 10027 Director Biotechnology No Revenues 06b false 2022-03-16 true true true true Note convertible into equity upon occurrence of certain events false 20000 3278840 3278840 0 The offering is closed and no amount is currently remaining to be sold. false 15 0 0 0 false Intrommune Therapeutics, Inc. /s/ Michael Nelson Michael Nelson President 2024-01-22